ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,203Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 6782

$2.21M Total Retail Price of All Prescriptions

Rank: 79 out of 6782

780 Patients Receiving at Least One Drug in Part D
37% Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 780 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 780 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 1,247 425 142 1 3
LISINOPRIL 1,185 529 171 2 4
METOPROLOL TARTRATE 980 273 139 3 13
SIMVASTATIN 954 371 123 4 1
RISPERIDONE 663 271 86 A 5 96
METFORMIN HCL 620 215 88 6 8
AMLODIPINE BESYLATE 614 336 91 7 2
OMEPRAZOLE 559 206 92 8 7
BENZTROPINE MESYLATE 529 227 72 R 9 190
ALENDRONATE SODIUM 449 110 58 10 14
QUETIAPINE FUMARATE 425 134 59 A 11 76
ABILIFY 416 109 49 A 12 156
OLANZAPINE 402 154 57 A 13 139
TRAZODONE HCL 379 143 58 14 50
LEVETIRACETAM 362 106 42 15 104
DIVALPROEX SODIUM ER 332 82 39 16 273
GABAPENTIN 311 123 48 17 15
ATORVASTATIN CALCIUM 293 94 42 18 5
LOSARTAN POTASSIUM 278 169 51 19 10
TAMSULOSIN HCL 275 127 41 20 21
IBUPROFEN 258 80 102 21 45
PAROXETINE HCL 257 86 36 22 77
DIVALPROEX SODIUM 256 70 36 23 112
PIOGLITAZONE HCL 250 87 29 R 24 65
FAMOTIDINE* 243 72 38 25 35
WARFARIN SODIUM 240 226 12 26 17
AMITRIPTYLINE HCL 230 99 48 R 27 117
MIRTAZAPINE 227 109 32 28 72
ESCITALOPRAM OXALATE 226 68 29 29 53
PANTOPRAZOLE SODIUM 210 69 34 30 28
DESMOPRESSIN ACETATE 210 59 27 10 30 423
SERTRALINE HCL 204 114 28 32 43
ADVAIR DISKUS 202 111 34 33 49
FLUOXETINE HCL 200 45 27 34 64
FUROSEMIDE 196 126 40 35 11
CARBAMAZEPINE 188 58 21 36 229
LANTUS 186 118 30 37 62
CYMBALTA 183 74 15 38 69
POLYETHYLENE GLYCOL 3350 181 36 32 39 114
MONTELUKAST SODIUM 178 49 27 40 47
VESICARE 174 66 20 41 123
JANUVIA 171 118 18 42 40
LAMOTRIGINE 171 33 24 42 269
SUBOXONE 169 41 30 S3 44 367
CLONIDINE HCL 164 71 34 45 60
NEXIUM 163 20 27 46 39
HYDROCODONE-ACETAMINOPHEN 161 102 43 S3 47 6
TOPIRAMATE 150 26 21 48 226
ATELVIA 148 34 12 49 124
BUSPIRONE HCL 148 33 23 49 197
OXCARBAZEPINE 143 52 17 51 390
LORAZEPAM 143 48 60 B 51 29
CARVEDILOL 142 102 22 53 23
SPIRIVA 140 70 29 54 61
VENLAFAXINE HCL ER 140 87 20 54 147
FINASTERIDE 135 67 22 56 67
DIOVAN 133 43 16 57 26
IBANDRONATE SODIUM 133 <11 17 57 113
HALOPERIDOL 130 40 24 A 59 311
AMITIZA 130 27 21 59 177
LITHIUM CARBONATE 128 70 16 61 424
PROAIR HFA 126 72 47 62 34
ATENOLOL 124 29 18 63 9
LOVAZA 124 25 11 63 66
POTASSIUM CHLORIDE 121 67 24 65 30
BENAZEPRIL HCL 121 55 15 65 27
VIMPAT 120 19 15 67 373
TRAMADOL HCL 120 93 23 67 32
CLOPIDOGREL 119 92 15 69 19
TERAZOSIN HCL 118 79 19 70 56
GEMFIBROZIL 116 19 17 71 101
TRIHEXYPHENIDYL HCL 114 12 14 R 72 545
METOPROLOL SUCCINATE 114 49 14 72 22
PHENYTOIN SODIUM EXTENDED 111 31 15 74 174
FLUDROCORTISONE ACETATE 109 27 14 75 425
SYNTHROID 108 39 19 76 63
PREDNISONE 107 56 19 77 57
GENERLAC 107 55 15 77 344
NAMENDA 104 <11 <11 79 36
PROPRANOLOL HCL 99 38 15 80 143
FLUTICASONE PROPIONATE 99 17 25 80 24
DONEPEZIL HCL 97 56 18 82 31
CLONAZEPAM 95 13 23 B 83 78
ZIPRASIDONE HCL 94 <11 <11 A 84 488
DOXEPIN HCL 88 36 18 85 411
NAPROXEN 84 17 22 86 92
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 44 56 87 132
NABUMETONE 81 <11 <11 88 199
PRAVASTATIN SODIUM 80 <11 <11 89 20
PRADAXA 79 <11 <11 90 237
ZOLPIDEM TARTRATE 78 39 29 91 18
LATUDA 76 44 12 A 92 465
RISPERDAL CONSTA 75 <11 <11 A 93 558
ACETAMINOPHEN-CODEINE 75 42 19 S3 93 93
CHLORPROMAZINE HCL 72 <11 <11 A 95 502
CITALOPRAM HBR 71 26 12 96 42
BD ULTRA-FINE PEN NEEDLE 71 <11 18 96 135
NOVOLOG 68 39 15 98 134
LACTULOSE 66 16 21 99 127
IPRATROPIUM-ALBUTEROL 65 38 12 100 170
SYMBICORT 65 31 12 100 141
DETROL LA 64 <11 <11 102 248
LOVASTATIN 63 <11 <11 103 16
LANTUS SOLOSTAR 62 24 14 104 106
BACLOFEN 62 <11 <11 104 89
BUPROPION HCL 60 14 13 106 429
ALLOPURINOL 59 <11 <11 107 33
TRIAMCINOLONE ACETONIDE 59 26 27 107 54
VENLAFAXINE HCL 58 <11 <11 109 366
ALPRAZOLAM 55 37 19 B 110 37
CEPHALEXIN 54 31 36 111 109
OLANZAPINE ODT 53 <11 <11 A 112 526
BUPROPION HCL SR 52 <11 <11 113 261
FLUPHENAZINE HCL 52 <11 <11 A 113 616
LANSOPRAZOLE 52 <11 <11 113 181
HEPARIN SODIUM 51 <11 <11 116 253
ROPINIROLE HCL 51 <11 <11 116 151
DIGOX 50 45* 12 118 94
MEGACE ES 50 21 13 R 118 407
PERMETHRIN 50 17 32 118 371
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.